isis pharmaceuticals inc
C. Frank Bennett BSc, Ph.D.
Senior Vice President of Antisense Research, Isis Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 3 different industries.|
As of Fiscal Year 2013
Dr. C. Frank Bennett, BSc, Ph.D. serves as Senior Vice President of Antisense Research at Isis Pharmaceuticals, Inc. Dr. Bennett served as Senior Vice President of Antisense Research of Isis Pharmaceuticals, Inc. since January 2006. Dr. Bennett is one of the founding members of Isis. He is involved in the development of antisense oligonucleotides as therapeutic agents, including research on the application of oligonucleotides for inflammatory and cancer targets, oligonucleotide ...
2855 Gazelle CourtPhone: 760-931-9200
Carlsbad, California 92010
Board Members Memberships*
Former Director and Member of the Scientific Advisory Board
Baylor College of Medicine
University of New Mexico
|Ali Mortazavi||Chief Executive and Director|
Silence Therapeutics plc
|George W. Hebard III, M.B.A||Interim Principal Executive Officer, Interim Chief Operating Officer and Secretary|
Enzon Pharmaceuticals Inc.
|Peter French B.Sc, M.Sc, Ph.D., MBA||Chief Executive Officer, Managing Director and Director|
Benitec Biopharma Limited
|Mark J. Murray Ph.D.||Chief Executive Officer, President and Director|
Tekmira Pharmaceuticals Corporation
|Kleanthis G. Xanthopoulos Ph.D.||Chief Executive Officer, President, Principal Financial & Accounting Officer and Director|
Regulus Therapeutics Inc.
|$600.0K||Compensation as of Fiscal Year 2012.|